日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-Term Clinical, Immunologic, and Viral Reservoir Outcomes in Children Treated With VRC01LS and 10-1074 Monoclonal Antibodies in the Tatelo Study

Tatelo 研究中接受 VRC01LS 和 10-1074 单克隆抗体治疗的儿童的长期临床、免疫学和病毒库结局

Ajibola, Gbolahan; Nelson, Bryan S; Niesar, Aischa; Hong, Seohyun; Lancien, Melanie; Holme, Molly Pretorius; Hughes, Michael D; Yin, Dwight E; Jean-Philippe, Patrick; Moyo, Sikhulile; Batlang, Oganne; Sakoi, Maureen; Maphorisa, Comfort; Mohammed, Terence; Lockman, Shahin; Makhema, Joseph; Kuritzkes, Daniel R; Lichterfeld, Mathias; Shapiro, Roger L

Evaluating Viral Load Sampling Schemes and Swabbing Methods for Optimal Surrogacy

评估病毒载量采样方案和拭子采样方法以实现最佳替代检测

Mateja, Allyson; Chu, Eric; Murray, Thomas A; Bramante, Carolyn T; Moser, Carlee; Givens, Naomi; Abdelghany, Mazin; Blair, Chris; Chen, Shuguang; Lat, Prince Kumar; Harari, Ofir; Kallewaard, Nicole L; Macpherson, Lisa Farmer; Boulware, David R; Suñer, Clara; Mitjà, Oriol; Adam, Stacey J; De Gruttola, Victor; Hughes, Michael D; Rubin, Daniel; Smith, Davey M; Potter, Gail E

Viral shedding and symptom severity across populations during acute COVID in the ACTIV-2 study

ACTIV-2 研究中急性 COVID 期间不同人群的病毒脱落和症状严重程度

Kung, Evelyn; Deo, Rinki; Choudhary, Manish C; Chew, Kara W; Evering, Teresa H; Ignacio, Rachel Bender; Jagannathan, Prasanna; Flynn, James P; Regan, James; Moser, Carlee; Giganti, Mark J; Hughes, Michael D; Ritz, Justin; Javan, Arzhang Cyrus; Greninger, Alexander L; Singh, Upinder; Fischer, William; Daar, Eric S; Wohl, David A; Eron, Joseph J; Currier, Judith S; Coombs, Robert W; Smith, Davey M; Li, Jonathan Z

Virological and drug-resistance outcomes for people living with HIV initiating or switching to tenofovir, lamivudine, and dolutegravir in six PEPFAR-supported countries: a prospective cohort study

在六个由美国总统艾滋病紧急救援计划(PEPFAR)支持的国家中,艾滋病毒感染者开始或改用替诺福韦、拉米夫定和多替拉韦治疗的病毒学和耐药性结果:一项前瞻性队列研究

Marc, Jean Bernard; McCarthy, Caitlyn; Wallis, Carole L; Kityo, Cissy; Hughes, Michael D; Godfrey, Catherine; Shah, N Sarita; Parikh, Urvi M; Maartens, Gary; Kanyike, Francis; Van Schalkwyk, Marije; Kihumuro, Raymond Bernard; Asiimwe, Philip; Tsikhutsu, Isaac; Munyanga, Cornelius; Some, Fatma F; Joseph, Yvetot; Flowers, Tracy; Mohapi, Lerato; Samaneka, Wadzanai P; Mponda, Kelvin; Rassool, Mohammed S; Pierre, Samuel; Woolley, Elizabeth; Manabe, Yukari C; Mellors, John W; Flexner, Charles; Koenig, Serena P; Mngqibisa, Rosie

Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial

恩西替利韦治疗非住院成人 COVID-19 患者:SCORPIO-HR 3 期随机、双盲、安慰剂对照试验结果

Luetkemeyer, Anne F; Chew, Kara W; Lacey, Stuart; Hughes, Michael D; Harrison, Linda J; Daar, Eric S; Eron, Joseph; Fletcher, Courtney V; Greninger, Alexander L; Hessinger, Diane; Li, Jonathan Z; Mailhot, David; Wohl, David; Chayakulkeeree, Methee; Mendoza, Jose Luis Accini; Elistratova, Polina; Makinde, Oluwaseun; Morgan, Gareth; Portsmouth, Simon; Uehara, Takeki; Smith, Davey; Currier, Judith S

The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death

在旨在降低28天住院率和/或死亡率的COVID-19治疗早期临床试验中,病毒载量终点的选择

Mateja, Allyson; Chu, Eric; Murray, Thomas A; Bramante, Carolyn T; Moser, Carlee; Givens, Naomi; Abdelghany, Mazin; Blair, Chris; Chen, Shuguang; Lat, Prince Kumar; Harari, Ofir; Kallewaard, Nicole L; Macpherson, Lisa Farmer; Boulware, David R; Suñer, Clara; Mitjà, Oriol; Adam, Stacey J; De Gruttola, Victor; Hughes, Michael D; Rubin, Daniel; Smith, Davey M; Potter, Gail E

Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial.

在随机安慰剂对照试验中,使用抗严重急性呼吸综合征冠状病毒 2 单克隆抗体疗法后出现病毒和症状反弹

Chew Kara W, McGinley Brooke, Moser Carlee, Li Jonathan Z, Evering Teresa H, Ritz Justin, Javan Arzhang Cyrus, Margolis David, Wohl David A, Hughes Michael D, Daar Eric S, Currier Judith S, Eron Joseph J, Smith Davey M

Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies

ACTIV-2 研究中,Tixagevimab/cilgavimab 或安慰剂治疗 COVID-19 的安全性、药代动力学以及中和抗体和抗药抗体

Bender Ignacio, Rachel A; Chew, Kara W; Moser, Carlee; Currier, Judith S; Eron, Joseph J; Javan, Arzhang Cyrus; Giganti, Mark J; Ritz, Justin; Gibbs, Michael; Kouekam, Hervé Tchouakam; Esser, Mark T; Daar, Eric S; Choudhary, Manish; Deo, Rinki; Fletcher, Courtney V; Li, Jonathan Z; Hughes, Michael D; Smith, Davey; Wohl, David Alain

Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy

通过肌内或静脉注射抗病毒单克隆抗体疗法快速清除可培养的SARS-CoV-2病毒

Deo, Rinki; Choudhary, Manish C; Glover, Owen T; Ignacio, Rachel Bender; Boucau, Julie; Chew, Kara W; Moser, Carlee; Currier, Judith S; Eron, Joseph J; Javan, Arzhang Cyrus; Giganti, Mark J; Aga, Evgenia; Gibbs, Michael; Cohen, Taylor; Streicher, Katie; Soboleva, Karina; Fletcher, Courtney V; Daar, Eric S; Greninger, Alexander L; Coombs, Robert W; Fischer, William; Hughes, Michael D; Smith, Davey; Wohl, David Alain; Barczak, Amy K; Li, Jonathan Z

Virology Outcomes of Tenofovir-lamivudine-dolutegravir in Treatment-naïve and Virologically Suppressed Individuals Switching From an NNRTI-based Regimen: An Observational Analysis at 13 Sites

替诺福韦-拉米夫定-多替拉韦治疗初治和病毒学抑制患者从基于非核苷类逆转录酶抑制剂(NNRTI)方案转换后的病毒学结果:13个研究中心的观察性分析

Kityo, Cissy; McCarthy, Caitlyn; Koenig, Serena P; Hughes, Michael D; Wallis, Carole L; Tsikhutsu, Isaac; Munyanga, Cornelius; Mwelase, Noluthando; Van Schalkwyk, Marije; Marc, Jean Bernard; Mponda, Kelvin; Dawson, Rodney; Some, Fatma F; Mohapi, Lerato; Joseph, Yvetot; Parikh, Urvi M; Shah, N Sarita; Manabe, Yukari C; Godfrey, Catherine; Woolley, Elizabeth; Mellors, John W; Flexner, Charles